EWHealthcareLarge-Cap

Edwards Lifesciences Corp Insider Trading Activity

Every SEC Form 4 insider transaction reported for Edwards Lifesciences Corp (EW), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are EW insiders buying or selling?

Edwards Lifesciences Corp insiders reported 2 open-market buys ($218.1K) and 493 sells ($661.5M) across 495 Form 4 filings — a net selling position of $661.3M.

Source: SEC EDGAR Form 4

Key Statistics (as of Jul 10, 2026)

Total Form 4 filings
495
SEC EDGAR
Insider filers
20
Insider buys (2)
$218.1K
Insider sells (493)
$661.5M

Insider sentiment

Net selling

Net insider flow of $661.3M in net selling.

Recent EW insider transactions

DateInsiderRoleTypeSharesPriceValue
Jul 10, 2026Daniel J. LippisCVP, TAVRSale619$91.70$56.8K
Jul 1, 2026Daniel J. LippisCVP, TAVRSale619$91.40$56.6K
Jun 18, 2026Bernard J ZovighianCEOSale523$87.92$46.0K
May 29, 2026Andrew M. DahlSVP, Corporate ControllerSale567.53$86.08$48.9K
May 27, 2026Donald E Bobo JRCVP,Strategy/Corp DevelopmentSale23.1K$86.42$2.0M
May 22, 2026Daveen ChopraCVP, TMTT & SurgicalSale1.5K$84.60$126.9K
May 18, 2026Daniel J. LippisCVP, TAVRSale620$81.14$50.3K
May 18, 2026Donald E Bobo JRCVP,Strategy/Corp DevelopmentSale18.0K$81.96$1.5M
May 12, 2026Bernard J ZovighianCEOSale36.4K$77.93$2.8M
May 12, 2026Wayne MarkowitzCVP, JAPACSale593$79.73$47.3K
May 4, 2026Daniel J. LippisCVP, TAVRSale2.0K$83.49$170.2K
Apr 9, 2026Scott B. UllemCVP, Chief Financial OfficerSale13.0K$80.04$1.0M
Apr 7, 2026Daniel J. LippisCVP, TAVRSale1.0K$80.98$82.5K
Apr 2, 2026Donald E Bobo JRCVP,Strategy/Corp DevelopmentSale22.7K$80.16$1.8M
Mar 11, 2026Scott B. UllemCVP, Chief Financial OfficerSale13.0K$84.92$1.1M
Mar 11, 2026Daniel J. LippisCVP, TAVRSale1.0K$85.38$87.0K
Mar 2, 2026Donald E Bobo JRCVP,Strategy/Corp DevelopmentSale11.3K$85.93$974.4K
Feb 27, 2026Donald E Bobo JRCVP,Strategy/Corp DevelopmentSale24.0K$83.84$2.0M
Feb 13, 2026Bernard J ZovighianCEOSale22.4K$76.67$1.7M
Jan 9, 2026Daniel J. LippisCVP, TAVRSale1.0K$85.70$87.3K
Jan 6, 2026Donald E Bobo JRCVP,Strategy/Corp DevelopmentSale11.3K$85.66$971.4K
Dec 12, 2025Donald E Bobo JRCVP,Strategy/Corp DevelopmentSale11.4K$83.76$953.7K
Dec 12, 2025Daniel J. LippisCVP, JAPACSale1.0K$84.03$85.6K
Dec 12, 2025Heisz Leslie StoneDirectorSale2.6K$83.41$218.1K
Dec 11, 2025Daveen ChopraCVP, TMTT & SurgicalSale2.0K$84.38$168.8K

Showing the 25 most recent of 495 Form 4 filings for Edwards Lifesciences Corp.

Most active EW insiders

  • Donald E Bobo JR103 filings
  • Michael A Mussallem74 filings
  • Larry L Wood64 filings
  • Catherine M. Szyman53 filings
  • Huimin Wang53 filings

Ask anything about EW insider activity

Use Trabud's AI agent to query Edwards Lifesciences Corp's Form 4 history in plain English — "Show me EW CEO purchases this year" or compare it against any other ticker.

Open the AI agent

EW insider trading FAQ

Are Edwards Lifesciences Corp insiders buying or selling?

Across 495 SEC Form 4 filings, Edwards Lifesciences Corp (EW) insiders reported 2 open-market purchases totaling $218.1K and 493 sales totaling $661.5M. That is a net selling position of $661.3M.

How many insiders trade EW stock?

20 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Edwards Lifesciences Corp. The most recent filing was accepted on Jul 10, 2026.

Where does Trabud get EW insider trading data?

All EW insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content